Literature DB >> 23271790

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Jennifer E Ho1, Asya Lyass, Douglas S Lee, Ramachandran S Vasan, William B Kannel, Martin G Larson, Daniel Levy.   

Abstract

BACKGROUND: About one half of patients with heart failure (HF) have preserved ejection fraction (HFPEF) rather than reduced ejection fraction (HFREF). The differences in risk factors predisposing to the 2 subtypes of HF are poorly understood. We sought to identify clinical predictors of new-onset HF and to explore differences in HFPEF versus HFREF. METHODS AND
RESULTS: We studied new-onset HF cases between 1981 and 2008 in Framingham Heart Study participants, classified into HFPEF and HFREF (ejection fraction >45% versus ≤45%). We used Cox multivariable regression to examine predictors of 8-year risk of incident HF and competing-risks analysis to identify predictors that differed between HFPEF and HFREF. Among 6340 participants (60±12 years) with 97 808 person-years of follow-up, 512 developed incident HF. Of 457 participants with left ventricular ejection fraction evaluation at the time of HF diagnosis, 196 (43%) were classified as HFPEF and 261 (56%) as HFREF. Fourteen predictors of overall HF were identified. Older age, diabetes mellitus, and a history of valvular disease predicted both types of HF (P≤0.0025 for all). Higher body mass index, smoking, and atrial fibrillation predicted HFPEF only, whereas male sex, higher total cholesterol, higher heart rate, hypertension, cardiovascular disease, left ventricular hypertrophy, and left bundle-branch block predicted risk of HFREF.
CONCLUSIONS: Although multiple risk factors preceded overall HF, distinct clusters of risk factors determine risk for new-onset HFPEF versus HFREF. This knowledge may enable the design of clinical trials of targeted prevention and the introduction of therapeutic strategies for prevention of HF and its 2 major subtypes.

Entities:  

Mesh:

Year:  2012        PMID: 23271790      PMCID: PMC3705220          DOI: 10.1161/CIRCHEARTFAILURE.112.972828

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  37 in total

1.  Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Authors:  E F Philbin; T A Rocco; N W Lindenmuth; K Ulrich; P L Jenkins
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

2.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

3.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

4.  Gender, age, and heart failure with preserved left ventricular systolic function.

Authors:  Frederick A Masoudi; Edward P Havranek; Grace Smith; Ronald H Fish; John F Steiner; Diana L Ordin; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

5.  Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.

Authors:  M J Lenzen; W J M Scholte op Reimer; E Boersma; P J M J Vantrimpont; F Follath; K Swedberg; J Cleland; M Komajda
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

Review 6.  The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

Authors:  Thomas J Wang; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

7.  Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.

Authors:  Philip Jong; Salim Yusuf; Michel F Rousseau; Sylvie A Ahn; Shrikant I Bangdiwala
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

Review 8.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.

Authors:  Karen Hogg; Karl Swedberg; John McMurray
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

9.  Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Sunil K Agarwal; Lloyd E Chambless; Christie M Ballantyne; Brad Astor; Alain G Bertoni; Patricia P Chang; Aaron R Folsom; Max He; Ron C Hoogeveen; Hanyu Ni; Pedro M Quibrera; Wayne D Rosamond; Stuart D Russell; Eyal Shahar; Gerardo Heiss
Journal:  Circ Heart Fail       Date:  2012-05-15       Impact factor: 8.790

10.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  108 in total

1.  Sex differences in new-onset heart failure.

Authors:  Sven Meyer; Frank P Brouwers; Adriaan A Voors; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Pim van der Harst; Michiel Rienstra; Isabelle C van Gelder; Dirk J van Veldhuisen; Wiek H van Gilst; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 2.  Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?

Authors:  Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2018-06

3.  Sex Differences in Metabolic Cardiomyopathy.

Authors:  Elizabeth Murphy; Georgios Amanakis; Natasha Fillmore; Randi J Parks; Junhui Sun
Journal:  Cardiovasc Res       Date:  2017-02-01       Impact factor: 10.787

Review 4.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

Review 5.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 6.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 7.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

8.  Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function.

Authors:  Ravi V Shah; Siddique A Abbasi; Bobak Heydari; Hoshang Farhad; John A Dodson; Jessie P Bakker; Roy M John; Aristidis Veves; Atul Malhotra; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong; Tomas G Neilan
Journal:  Am Heart J       Date:  2014-01-15       Impact factor: 4.749

Review 9.  Heart failure with preserved ejection fraction: emerging drug strategies.

Authors:  Fouad A Zouein; Lisandra E de Castro Brás; Danielle V da Costa; Merry L Lindsey; Mazen Kurdi; George W Booz
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

10.  Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.

Authors:  David P Kao; James D Lewsey; Inder S Anand; Barry M Massie; Michael R Zile; Peter E Carson; Robert S McKelvie; Michel Komajda; John J V McMurray; JoAnn Lindenfeld
Journal:  Eur J Heart Fail       Date:  2015-08-06       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.